Mounting redemption requests across private credit funds are raising fresh questions about the resilience of one of the fastest-growing corners of the global…
Day One Biopharmaceuticals (NASDAQ: DAWN) ripped higher on Friday morning after Servier signed a definitive agreement to acquire the California-based firm for about…
